Recorded Chinese product: 磷霉素钙片磷霉素钙片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司
主要成分Active Ingredients
- 磷霉素钙Linmei Sugai
药物知识说明
磷霉素钙是一种在国家药监局注册认定的药品。该药品含有磷霉素钙-bab67ab2等成分。
该药品关联的活性成分包括：磷霉素钙Linmei Sugai。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司。
您可以探索含有相同成分的其他药品：磷霉素钙-bab67ab2成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 磷霉素钙片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 磷霉素钙Linmei Sugai.
Manufacturers recorded for this product: 赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司.
Explore other medicines containing the same ingredient: 磷霉素钙 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 磷霉素钙片Recorded Chinese product: 磷霉素钙片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.1g(以磷霉素计)Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20003370
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20003370
Manufacturer
Chinese legal name: 赤峰蒙欣药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20003370
生产企业
赤峰蒙欣药业有限公司(国产)
适应症
本品口服适用于对磷霉素敏感的致病菌所致的下列感染:|1.肠道感染:细菌性肠炎、菌痢。|2.泌尿系统感染:膀胱炎、肾盂肾炎、尿道炎。|3.皮肤科及软组织感染:疖病、炭疽、汗腺炎、淋巴结炎、毛囊炎。|4.呼吸道感染:鼻咽炎、扁桃体炎、气管炎、早期慢性支气管炎。|5.眼科:麦粒肿、泪囊炎。|6.妇科:阴道炎、子宫颈炎。
用法用量
口服。|1.成人每日以磷霉素酸计2～4g（4～8片）;|2.小儿每日按体重一次50～100mg/kg,一日3～4次。
不良反应
1.主要为轻度胃肠道反应,如恶心、胃纳减退、中上腹不适、稀便或轻度腹泻等。|2.一般不影响继续用药,偶可发生皮疹、嗜酸粒细胞增多、丙氨酸氨基转移酶升高等,未见肾、血液系统等的毒性反应。
禁忌
对本品成分过敏者禁用。
注意事项
1.与β内酰胺类、氨基糖苷类等抗生素联用时常呈协同作用,并可减少或延迟细菌耐药性的产生。|2.磷霉素在体外对二磷酸腺苷（ADP）介导的血小板凝集有抑制作用,剂量加大时更为显著。
贮藏
遮光，密封保存。
规格
0.1g(以磷霉素计)
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.